Zacks Research Comments on Allstate FY2025 Earnings

The Allstate Corporation (NYSE:ALL) – Investment analysts at Zacks Research issued their FY2025 earnings per share (EPS) estimates for shares of Allstate in a note issued to investors on Wednesday, November 19th. Zacks Research analyst Team expects that the insurance provider will earn $27.64 per share for the year. The consensus estimate for Allstate’s current full-year earnings is $18.74 per share. Zacks Research also issued estimates for Allstate’s Q4 2025 earnings at $7.00 EPS, Q2 2026 earnings at $3.49 EPS, Q3 2026 earnings at $4.94 EPS, Q1 2027 earnings at $6.54 EPS, Q2 2027 earnings at $4.81 EPS, Q3 2027 earnings at $4.85 EPS and FY2027 earnings at $24.41 EPS.

A number of other brokerages have also issued reports on ALL. Wall Street Zen lowered shares of Allstate from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 8th. Raymond James Financial reaffirmed a “strong-buy” rating and set a $260.00 price objective (up previously from $250.00) on shares of Allstate in a research report on Monday, August 4th. Wells Fargo & Company lifted their target price on Allstate from $202.00 to $216.00 and gave the stock an “equal weight” rating in a research report on Friday, November 7th. Cantor Fitzgerald upgraded Allstate to a “hold” rating in a research report on Wednesday, August 13th. Finally, Jefferies Financial Group upped their target price on Allstate from $254.00 to $255.00 and gave the company a “buy” rating in a research note on Monday, August 11th. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $237.64.

Allstate Stock Performance

Shares of ALL opened at $214.28 on Friday. The company has a market capitalization of $56.07 billion, a PE ratio of 10.07, a price-to-earnings-growth ratio of 0.69 and a beta of 0.35. The company’s fifty day moving average price is $203.39 and its 200 day moving average price is $202.07. Allstate has a one year low of $176.00 and a one year high of $215.89. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43.

Allstate (NYSE:ALL) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $11.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.48 by $5.69. Allstate had a return on equity of 28.74% and a net margin of 8.79%.The firm had revenue of $17.26 billion during the quarter, compared to analysts’ expectations of $16.59 billion. During the same quarter in the prior year, the business earned $3.91 earnings per share. The company’s revenue was up 3.8% on a year-over-year basis.

Institutional Investors Weigh In On Allstate

Several institutional investors and hedge funds have recently made changes to their positions in the company. Avantax Advisory Services Inc. increased its holdings in shares of Allstate by 3.1% during the second quarter. Avantax Advisory Services Inc. now owns 23,573 shares of the insurance provider’s stock worth $4,745,000 after purchasing an additional 704 shares during the period. Atlas Capital Advisors Inc. grew its position in Allstate by 197.3% during the first quarter. Atlas Capital Advisors Inc. now owns 6,712 shares of the insurance provider’s stock worth $1,390,000 after buying an additional 4,454 shares in the last quarter. Commonwealth Retirement Investments LLC increased its stake in Allstate by 103.5% during the 2nd quarter. Commonwealth Retirement Investments LLC now owns 12,960 shares of the insurance provider’s stock worth $2,609,000 after acquiring an additional 6,590 shares during the period. Zurich Insurance Group Ltd FI acquired a new position in Allstate in the 1st quarter valued at $22,405,000. Finally, Advisors Capital Management LLC acquired a new position in Allstate in the 1st quarter valued at $301,000. Institutional investors and hedge funds own 76.47% of the company’s stock.

Insider Activity at Allstate

In related news, insider Suren Gupta sold 1,400 shares of the business’s stock in a transaction on Friday, November 14th. The stock was sold at an average price of $215.02, for a total value of $301,028.00. Following the sale, the insider owned 101,031 shares of the company’s stock, valued at $21,723,685.62. The trade was a 1.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.70% of the stock is owned by company insiders.

Allstate Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Stockholders of record on Monday, December 1st will be issued a $1.00 dividend. The ex-dividend date of this dividend is Monday, December 1st. This represents a $4.00 dividend on an annualized basis and a dividend yield of 1.9%. Allstate’s dividend payout ratio is presently 12.95%.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.